Search

Nianxiang Zou

Examiner (ID: 10628, Phone: (571)272-2850 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1648, 1671
Total Applications
845
Issued Applications
504
Pending Applications
89
Abandoned Applications
294

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18565756 [patent_doc_number] => 20230256083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => SELF-AMPLIFYING SARS-COV-2 RNA VACCINE [patent_app_type] => utility [patent_app_number] => 18/001912 [patent_app_country] => US [patent_app_date] => 2021-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001912 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001912
SELF-AMPLIFYING SARS-COV-2 RNA VACCINE Jun 17, 2021 Pending
Array ( [id] => 19091203 [patent_doc_number] => 11952637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-09 [patent_title] => Rapid low-cost detection of SARS-CoV-2 using isothermal amplification and sensing methods [patent_app_type] => utility [patent_app_number] => 18/001395 [patent_app_country] => US [patent_app_date] => 2021-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 27 [patent_no_of_words] => 10637 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001395 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001395
Rapid low-cost detection of SARS-CoV-2 using isothermal amplification and sensing methods Jun 10, 2021 Issued
Array ( [id] => 17244773 [patent_doc_number] => 20210364516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => ULTRA-SENSITIVE, FAST, PLASMONIC-FLUOR ENHANCED ASSAY FOR SARS-COV-2 IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 17/303063 [patent_app_country] => US [patent_app_date] => 2021-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15112 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17303063 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/303063
ULTRA-SENSITIVE, FAST, PLASMONIC-FLUOR ENHANCED ASSAY FOR SARS-COV-2 IMMUNE RESPONSE May 18, 2021 Abandoned
Array ( [id] => 18603445 [patent_doc_number] => 11744885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-05 [patent_title] => Vaccines for recurrent respiratory papillomatosis and methods of using the same [patent_app_type] => utility [patent_app_number] => 17/320944 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28827 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320944 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/320944
Vaccines for recurrent respiratory papillomatosis and methods of using the same May 13, 2021 Issued
Array ( [id] => 17229908 [patent_doc_number] => 20210356465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => NEUTRALIZING ANTIBODY TESTING AND TREATMENT [patent_app_type] => utility [patent_app_number] => 17/319081 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11817 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319081 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/319081
Neutralizing antibody testing and treatment May 11, 2021 Issued
Array ( [id] => 19389880 [patent_doc_number] => 20240279750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => Diagnostic Primers, Kits and Methods for Viral Detection [patent_app_type] => utility [patent_app_number] => 17/923444 [patent_app_country] => US [patent_app_date] => 2021-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923444 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923444
Diagnostic Primers, Kits and Methods for Viral Detection May 4, 2021 Pending
Array ( [id] => 18738015 [patent_doc_number] => 20230346920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => VACCINES AGAINST VIRAL PATHOGENS [patent_app_type] => utility [patent_app_number] => 17/997886 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997886
VACCINES AGAINST VIRAL PATHOGENS May 3, 2021 Pending
Array ( [id] => 18738015 [patent_doc_number] => 20230346920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => VACCINES AGAINST VIRAL PATHOGENS [patent_app_type] => utility [patent_app_number] => 17/997886 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997886
VACCINES AGAINST VIRAL PATHOGENS May 3, 2021 Pending
Array ( [id] => 18406908 [patent_doc_number] => 20230168259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => METHOD FOR PREDICTING THE COURSE OF A VIRAL DISEASE [patent_app_type] => utility [patent_app_number] => 17/995728 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6882 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995728 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995728
METHOD FOR PREDICTING THE COURSE OF A VIRAL DISEASE Apr 29, 2021 Pending
Array ( [id] => 17784913 [patent_doc_number] => 11408026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-09 [patent_title] => Methods of predicting susceptibility to infectious disease and related methods of treatment [patent_app_type] => utility [patent_app_number] => 17/240991 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11360 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240991 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/240991
Methods of predicting susceptibility to infectious disease and related methods of treatment Apr 25, 2021 Issued
Array ( [id] => 17193400 [patent_doc_number] => 11162143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-02 [patent_title] => Methods for generating therapeutic delivery platforms [patent_app_type] => utility [patent_app_number] => 17/236561 [patent_app_country] => US [patent_app_date] => 2021-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 50 [patent_no_of_words] => 28015 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236561 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/236561
Methods for generating therapeutic delivery platforms Apr 20, 2021 Issued
Array ( [id] => 16990286 [patent_doc_number] => 20210228706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => IMMUNE COMPLEX [patent_app_type] => utility [patent_app_number] => 17/301626 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301626 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/301626
Immune complex Apr 8, 2021 Issued
Array ( [id] => 18610915 [patent_doc_number] => 20230277645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA [patent_app_type] => utility [patent_app_number] => 17/221032 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13644 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/221032
COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA Apr 1, 2021 Pending
Array ( [id] => 18610915 [patent_doc_number] => 20230277645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA [patent_app_type] => utility [patent_app_number] => 17/221032 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13644 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/221032
COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA Apr 1, 2021 Pending
Array ( [id] => 18296431 [patent_doc_number] => 20230106117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN SUBJECTS USING MICROCHANNEL DELIVERY DEVICES [patent_app_type] => utility [patent_app_number] => 17/909688 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17354 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909688 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/909688
SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN SUBJECTS USING MICROCHANNEL DELIVERY DEVICES Mar 7, 2021 Pending
Array ( [id] => 17065882 [patent_doc_number] => 20210268097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES [patent_app_type] => utility [patent_app_number] => 17/194779 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18724 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194779 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194779
Vaccines against HPV and HPV-related diseases Mar 7, 2021 Issued
Array ( [id] => 18420616 [patent_doc_number] => 20230175079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => METHOD FOR DETECTING SINGLE-STRANDED RNA VIRUS [patent_app_type] => utility [patent_app_number] => 17/904897 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9462 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 382 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904897 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/904897
METHOD FOR DETECTING SINGLE-STRANDED RNA VIRUS Feb 23, 2021 Pending
Array ( [id] => 18737804 [patent_doc_number] => 20230346700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors [patent_app_type] => utility [patent_app_number] => 17/800687 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27615 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800687 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/800687
Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors Feb 18, 2021 Pending
Array ( [id] => 19210919 [patent_doc_number] => 11999967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-04 [patent_title] => Generating HPV antigen-specific cells from a naive T cell population [patent_app_type] => utility [patent_app_number] => 17/168461 [patent_app_country] => US [patent_app_date] => 2021-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6271 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 310 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168461 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/168461
Generating HPV antigen-specific cells from a naive T cell population Feb 4, 2021 Issued
Array ( [id] => 18335859 [patent_doc_number] => 20230127808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => AD7-VECTORED VACCINE FOR PREVENTING SARS- COV-2 INFECTION [patent_app_type] => utility [patent_app_number] => 17/598659 [patent_app_country] => US [patent_app_date] => 2021-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2556 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598659 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/598659
AD7-VECTORED VACCINE FOR PREVENTING SARS- COV-2 INFECTION Feb 1, 2021 Pending
Menu